The Pretreatment Albumin to Globulin Ratio Has Predictive Value for Long-Term Mortality in Nasopharyngeal Carcinoma
Figure 1
Distant metastasis-free survival (DMFS) rates for patients with nasopharyngeal carcinoma (NPC) with a pretreatment serum albumin/globulin ratio (AGR) <1.4 (dashed line) or ≥1.4 (solid line).